TME Pharma and the Market

TME Pharma's Ordinary Shares

• Date of the IPO: September 28, 2016
• ISIN / Mnemo : NL0015000YE1 / ALTME
• Stock exchange: Euronext Growth Paris
• Fiscal year end : December 31
• Number of shares (June 28, 2024): 42,183,371*
• Liquidity contract: Invest Securities

*Taking into account the shares issuance following the exercise of Warrants Z as published on June 28, 2024.

Analyst Coverage

Firm	Analyst	latest Reports (more)
Invest Securities	Jamila El Bougrini, PhD	2024, July 18 (EN/FR) 2024, June 27 (EN/FR) 2024, June 19 (EN/FR)
In Extenso	Jean-Pierre Loza, PhD	2023, November 06 (EN/FR) 2023, September 25 (EN/FR) 2023, July 05 (EN/FR)

TME Pharma N.V. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding TME Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of TME Pharma or its management. TME Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

TME Pharma's Warrants Z

• ISIN NL0015001SR3
• Stock exchange: Euronext Growth Paris
• Number of Warrants Z (June 28, 2024): 2,812,632

Rapid access to French brokers